- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
CDT1 Antibody / DNA Replication Licensing Factor Antibody is designed for the detection and study of CDT1 (Chromatin Licensing and DNA Replication Factor 1), a critical regulator of DNA replication that ensures accurate duplication of the genome during cell division. CDT1 functions during the G1 phase of the cell cycle by licensing replication origins before DNA synthesis begins, thereby preparing chromosomal DNA for faithful replication during S phase. Because genome duplication must occur precisely once per cell cycle, CDT1 serves as an essential component of the molecular machinery that maintains genomic integrity and cellular viability.
As a DNA replication licensing factor, CDT1 participates in assembly of the pre-replication complex through recruitment and loading of the MCM helicase complex onto chromatin. This licensing event establishes replication competence and allows DNA synthesis to proceed at the appropriate stage of the cell cycle. Tight regulation of CDT1 activity is required to prevent re-replication of genomic DNA, a potentially harmful event that can result in DNA damage, chromosomal abnormalities, and genomic instability. Multiple regulatory mechanisms therefore control CDT1 abundance and activity throughout the cell cycle to ensure proper replication origin usage.
CDT1 plays a central role in cellular proliferation and is closely associated with actively dividing cell populations. Expression of CDT1 is frequently examined in studies of cell cycle progression, developmental biology, stem cell regulation, and tissue growth. Because DNA replication licensing is fundamental to cellular expansion and tissue maintenance, CDT1 remains an important marker for investigating mechanisms that govern normal cell division and proliferative capacity across diverse biologic systems.
Disruption of CDT1 regulation has been linked to replication stress, chromosome instability, and abnormal cell cycle progression. Consequently, CDT1 has become a significant target in research involving cancer biology, DNA damage responses, genome maintenance pathways, and cellular checkpoint regulation. Studies examining CDT1 help researchers understand how replication licensing pathways contribute to preservation of genomic stability and how defects in these mechanisms may promote disease development.
CDT1 Antibody is widely used to investigate DNA replication licensing pathways, cell cycle regulation, and molecular mechanisms controlling genome duplication. Researchers utilize CDT1 Antibody reagents to evaluate protein expression patterns, characterize replication-associated signaling networks, and study biologic processes involved in cellular proliferation, chromosome maintenance, developmental regulation, and genomic stability. As interest in replication control mechanisms continues to expand, CDT1 remains an important target in both basic and translational research.
Explore additional antibodies to cell cycle regulators, DNA replication proteins, and genome maintenance factors on our Cell Biology Antibodies page.
Optimal dilution of the CDT1 Antibody / DNA Replication Licensing Factor Antibody should be determined by the researcher.
Recombinant human protein (amino acids D508-L546) was used as the immunogen for the CDT1 antibody.
After reconstitution, the CDT1 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
CDT1 Antibody, Chromatin Licensing and DNA Replication Factor 1 Antibody, DNA Replication Licensing Factor Antibody, Replication Licensing Protein Antibody, DNA Replication Initiation Factor Antibody, Genome Stability Protein Antibody, Cell Cycle Licensing Factor Antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.